What does Arcturus Therapeutics Holdings Inc. do?
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032…
What is Arcturus Therapeutics Holdings Inc.'s P/E and P/B ratio?
Arcturus Therapeutics Holdings Inc. has a P/E ratio of -3.2 and a P/B ratio of 1.78.
What is Arcturus Therapeutics Holdings Inc.'s debt-to-equity ratio?
Arcturus Therapeutics Holdings Inc. has a debt-to-equity ratio of 0.13.
How much does Arcturus Therapeutics Holdings Inc. owe compared with what it owns?
Arcturus Therapeutics Holdings Inc. owes $0.23 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Arcturus Therapeutics Holdings Inc.'s Positivity rank?
Arcturus Therapeutics Holdings Inc. is ranked #3,907 of 6,774 companies globally and #1,817 of 4,000 in United States on PositoAI, with a Positivity Score of 20,108.
Does Arcturus Therapeutics Holdings Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Arcturus Therapeutics Holdings Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Quarterly report filed late (NT 10-Q).
Where can I read the latest news about Arcturus Therapeutics Holdings Inc.?
Recent headlines about Arcturus Therapeutics Holdings Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Arcturus Therapeutics Holdings Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Arcturus Therapeutics Holdings Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.